compare tirzepatide and retatrutide vs #tirzepatide at a glance… #onthepen Difference between tirzepatide and retatrutide:

Ozempic was submitted to the FDA for the treatment of patients with T2DM and peripheral artery disease (PAD)

Here is the data on what happens to reconstituted retatrutide left at approximately 25 degrees Celsius: Day 1 to 3: Minimal measurable degradation, perhaps 1 to 3 percent potency loss

According to the World Health Organization (WHO), the global prevalence of obesity has nearly tripled since 1975

Foundayo is FDA-approved for adults with obesity or overweight with at least one weight-related condition

Health Canada typically reviews medications 6 to 12 months after FDA approval, meaning Canadian access could lag US availability by up to a year